Tae Min Kim (Miso Kim, Tae-Min Kim, T M Kim)

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 58

Top Topics

Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

Investigational new drugs

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Omid Hamid, Karl D Lewis, Amy Weise, Meredith A McKean, Kyriakos P Papadopoulos, John Crown, Tae Min Kim, Dae Ho Lee, Sajeve S Thomas, Janice Mehnert, John Kaczmar, Nehal J Lakhani, Kevin B Kim, Mark Ross Middleton, Guilherme Rabinowits, Alexander I Spira, Melinda Yushak, Inderjit Mehmi, Fang Fang, Shuquan Chen, Jayakumar Mani, Vladimir Jankovic, Fang Wang, Nathalie Fiaschi, Laura Brennan, Anne J Paccaly, Sheila Masinde, Mark Salvati, Matthew G Fury, Glenn S Kroog, Israel Lowy, Giuseppe Gullo
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Andrew J Armstrong, Ravit Geva, Hyun Cheol Chung, Charlotte Lemech, Wilson H Miller, Aaron R Hansen, Jong-Seok Lee, Frank Tsai, Benjamin J Solomon, Tae Min Kim, Christian Rolfo, Vincent Giranda, Yixin Ren, Fang Liu, Bhargava Kandala, Tomoko Freshwater, Judy S Wang
CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial. Investigational new drugs 42 (1) (2024)
Songji Oh, Tae Min Kim
Histological transformation to small-cell carcinoma. Nature reviews. Cancer (2024)
Andrew J Armstrong, Ravit Geva, Hyun Cheol Chung, Charlotte Lemech, Wilson H Miller, Aaron R Hansen, Jong-Seok Lee, Frank Tsai, Benjamin J Solomon, Tae Min Kim, Christian Rolfo, Vincent Giranda, Yixin Ren, Fang Liu, Bhargava Kandala, Tomoko Freshwater, Judy S Wang
CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial. Investigational new drugs (2024)
Andrew J Armstrong, Ravit Geva, Hyun Cheol Chung, Charlotte Lemech, Wilson H Miller, Aaron R Hansen, Jong-Seok Lee, Frank Tsai, Benjamin J Solomon, Tae Min Kim, Christian Rolfo, Vincent Giranda, Yixin Ren, Fang Liu, Bhargava Kandala, Tomoko Freshwater, Judy S Wang
CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial. Investigational new drugs 42 (1) (2024)
Sangsin Lee, Seung Geun Song, Gwanghun Kim, Sehui Kim, Hyun Jung Yoo, Jaemoon Koh, Ye-Ji Kim, Jingwen Tian, Eunji Cho, Youn Soo Choi, Sunghoe Chang, Hyun Mu Shin, Kyeong Cheon Jung, Ji Hoon Kim, Tae Min Kim, Yoon Kyung Jeon, Hye-Young Kim, Minho Shong, Ji Hyung Kim, Doo Hyun Chung
CRIF1 deficiency induces FOXP3 LOW inflammatory non-suppressive regulatory T cells, thereby promoting antitumor immunity. Science advances 10 (13) (2024)
Sangsin Lee, Seung Geun Song, Gwanghun Kim, Sehui Kim, Hyun Jung Yoo, Jaemoon Koh, Ye-Ji Kim, Jingwen Tian, Eunji Cho, Youn Soo Choi, Sunghoe Chang, Hyun Mu Shin, Kyeong Cheon Jung, Ji Hoon Kim, Tae Min Kim, Yoon Kyung Jeon, Hye-Young Kim, Minho Shong, Ji Hyung Kim, Doo Hyun Chung
CRIF1 deficiency induces FOXP3 LOW inflammatory non-suppressive regulatory T cells, thereby promoting antitumor immunity. Science advances 10 (13) (2024)
Andrew J Armstrong, Ravit Geva, Hyun Cheol Chung, Charlotte Lemech, Wilson H Miller, Aaron R Hansen, Jong-Seok Lee, Frank Tsai, Benjamin J Solomon, Tae Min Kim, Christian Rolfo, Vincent Giranda, Yixin Ren, Fang Liu, Bhargava Kandala, Tomoko Freshwater, Judy S Wang
CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial. Investigational new drugs 42 (1) (2024)
Andrew J Armstrong, Ravit Geva, Hyun Cheol Chung, Charlotte Lemech, Wilson H Miller, Aaron R Hansen, Jong-Seok Lee, Frank Tsai, Benjamin J Solomon, Tae Min Kim, Christian Rolfo, Vincent Giranda, Yixin Ren, Fang Liu, Bhargava Kandala, Tomoko Freshwater, Judy S Wang
CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial. Investigational new drugs 42 (1) (2024)
Songji Oh, Jaemoon Koh, Tae Min Kim, Soyeon Kim, Jeonghwan Youk, Miso Kim, Bhumsuk Keam, Yoon Kyung Jeon, Ja-Lok Ku, Dong Wan Kim, Doo Hyun Chung, Dae Seog Heo
Transcriptomic heterogeneity of EGFR-mutant non-small cell lung cancer evolution towards small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Songji Oh, Tae Min Kim
Histological transformation to small-cell carcinoma. Nature reviews. Cancer 24 (7) (2024)
Andrew J Armstrong, Ravit Geva, Hyun Cheol Chung, Charlotte Lemech, Wilson H Miller, Aaron R Hansen, Jong-Seok Lee, Frank Tsai, Benjamin J Solomon, Tae Min Kim, Christian Rolfo, Vincent Giranda, Yixin Ren, Fang Liu, Bhargava Kandala, Tomoko Freshwater, Judy S Wang
CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial. Investigational new drugs 42 (1) (2024)
Pier Luigi Luigi Zinzani, Huaqing Wang, Jifeng Feng, Tae Min Kim, Rong Tao, Huilai Zhang, Laura Maria Fogliatto, Clara Maluquer Artigal, Muhit Özcan, Eduardo Patricio Yanez Ruiz, Won Seog Kim, Dmitry Kirtbaya, Iryna Kriachok, Felipe Maciel, Hongwei Xue, Krimo Bouabdallah, Charles Phelps, Shalini Chaturvedi, Anke Weispfenning, Peter N Morcos, Fatuma Catherine Atieno Odongo, Viktoriya Buvaylo, Barrett H Childs, Martin Dreyling, Matthew J Matasar, Paola Ghione
CHRONOS-4: Phase 3 study of copanlisib plus rituximab-based immunochemotherapy in relapsed indolent B-cell lymphoma. Blood advances (2024)
Pier Luigi Luigi Zinzani, Huaqing Wang, Jifeng Feng, Tae Min Kim, Rong Tao, Huilai Zhang, Laura Maria Fogliatto, Clara Maluquer Artigal, Muhit Özcan, Eduardo Patricio Yanez Ruiz, Won Seog Kim, Dmitry Kirtbaya, Iryna Kriachok, Felipe Maciel, Hongwei Xue, Krimo Bouabdallah, Charles Phelps, Shalini Chaturvedi, Anke Weispfenning, Peter N Morcos, Fatuma Catherine Atieno Odongo, Viktoriya Buvaylo, Barrett H Childs, Martin Dreyling, Matthew J Matasar, Paola Ghione
CHRONOS-4: Phase 3 study of copanlisib plus rituximab-based immunochemotherapy in relapsed indolent B-cell lymphoma. Blood advances (2024)
Omid Hamid, Karl D Lewis, Amy Weise, Meredith A McKean, Kyriakos P Papadopoulos, John Crown, Tae Min Kim, Dae Ho Lee, Sajeve S Thomas, Janice Mehnert, John Kaczmar, Nehal J Lakhani, Kevin B Kim, Mark Ross Middleton, Guilherme Rabinowits, Alexander I Spira, Melinda Yushak, Inderjit Mehmi, Fang Fang, Shuquan Chen, Jayakumar Mani, Vladimir Jankovic, Fang Wang, Nathalie Fiaschi, Laura Brennan, Anne J Paccaly, Sheila Masinde, Mark Salvati, Matthew G Fury, Glenn S Kroog, Israel Lowy, Giuseppe Gullo
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Omid Hamid, Karl D Lewis, Amy Weise, Meredith A McKean, Kyriakos P Papadopoulos, John Crown, Tae Min Kim, Dae Ho Lee, Sajeve S Thomas, Janice Mehnert, John Kaczmar, Nehal J Lakhani, Kevin B Kim, Mark Ross Middleton, Guilherme Rabinowits, Alexander I Spira, Melinda Yushak, Inderjit Mehmi, Fang Fang, Shuquan Chen, Jayakumar Mani, Vladimir Jankovic, Fang Wang, Nathalie Fiaschi, Laura Brennan, Anne J Paccaly, Sheila Masinde, Mark Salvati, Matthew G Fury, Glenn S Kroog, Israel Lowy, Giuseppe Gullo
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Omid Hamid, Karl D Lewis, Amy Weise, Meredith A McKean, Kyriakos P Papadopoulos, John Crown, Tae Min Kim, Dae Ho Lee, Sajeve S Thomas, Janice Mehnert, John Kaczmar, Nehal J Lakhani, Kevin B Kim, Mark Ross Middleton, Guilherme Rabinowits, Alexander I Spira, Melinda Yushak, Inderjit Mehmi, Fang Fang, Shuquan Chen, Jayakumar Mani, Vladimir Jankovic, Fang Wang, Nathalie Fiaschi, Laura Brennan, Anne J Paccaly, Sheila Masinde, Mark Salvati, Matthew G Fury, Glenn S Kroog, Israel Lowy, Giuseppe Gullo
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Andrew J Armstrong, Ravit Geva, Hyun Cheol Chung, Charlotte Lemech, Wilson H Miller, Aaron R Hansen, Jong-Seok Lee, Frank Tsai, Benjamin J Solomon, Tae Min Kim, Christian Rolfo, Vincent Giranda, Yixin Ren, Fang Liu, Bhargava Kandala, Tomoko Freshwater, Judy S Wang
CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial. Investigational new drugs 42 (1) (2024)
Andrew J Armstrong, Ravit Geva, Hyun Cheol Chung, Charlotte Lemech, Wilson H Miller, Aaron R Hansen, Jong-Seok Lee, Frank Tsai, Benjamin J Solomon, Tae Min Kim, Christian Rolfo, Vincent Giranda, Yixin Ren, Fang Liu, Bhargava Kandala, Tomoko Freshwater, Judy S Wang
Correction to: CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial. Investigational new drugs (2024)
Andrew J Armstrong, Ravit Geva, Hyun Cheol Chung, Charlotte Lemech, Wilson H Miller, Aaron R Hansen, Jong-Seok Lee, Frank Tsai, Benjamin J Solomon, Tae Min Kim, Christian Rolfo, Vincent Giranda, Yixin Ren, Fang Liu, Bhargava Kandala, Tomoko Freshwater, Judy S Wang
CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial. Investigational new drugs 42 (1) (2024)
Andrew J Armstrong, Ravit Geva, Hyun Cheol Chung, Charlotte Lemech, Wilson H Miller, Aaron R Hansen, Jong-Seok Lee, Frank Tsai, Benjamin J Solomon, Tae Min Kim, Christian Rolfo, Vincent Giranda, Yixin Ren, Fang Liu, Bhargava Kandala, Tomoko Freshwater, Judy S Wang
CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial. Investigational new drugs 42 (1) (2024)
Sangsin Lee, Seung Geun Song, Gwanghun Kim, Sehui Kim, Hyun Jung Yoo, Jaemoon Koh, Ye-Ji Kim, Jingwen Tian, Eunji Cho, Youn Soo Choi, Sunghoe Chang, Hyun Mu Shin, Kyeong Cheon Jung, Ji Hoon Kim, Tae Min Kim, Yoon Kyung Jeon, Hye-Young Kim, Minho Shong, Ji Hyung Kim, Doo Hyun Chung
CRIF1 deficiency induces FOXP3 LOW inflammatory non-suppressive regulatory T cells, thereby promoting antitumor immunity. Science advances 10 (13) (2024)
Daniel Shao-Weng Tan, Enriqueta Felip Font, Gilberto de Castro Junior, Benjamin J Solomon, Alastair P Greystoke, Byoung Chul Cho, Manuel Cobo, Tae Min Kim, Sandip Ganguly, Enric Carcereny, Luis G Paz-Ares, Jaafar Bennouna, Marina-Chiara Garassino, Michael Schenker, Sang-We Kim, Jan C Brase, Denise Bury-Maynard, Vanessa Q Passos, Stéphanie Deudon, Bharani Dharan, Yuanbo Song, Rafael Caparica, Bruce E Johnson
Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Heejoon Jang, Su Jong Yu, Mark Hong Lee, Tae Min Kim, Yun Bin Lee, Eun-Ju Cho, Jeong-Hoon Lee, Jung Hwan Yoon, Yun Joon Kim
Efficacy of Antiviral Prophylaxis up to 6 or 12 Months From Completion of Rituximab in Resolved Hepatitis B Patients: A Multicenter, Randomized Study. Journal of Korean medical science 38 (28) (2023)
Seyoung Seo, Bhumsuk Keam, Seong Hoon Shin, Yee Soo Chae, Tae Min Kim, Lee Chun Park, Seung-Beom Hong, Myung-Ju Ahn, Sung-Bae Kim
A phase Ia/Ib study of novel anti-ErbB3 monoclonal antibody, barecetamab (ISU104) in refractory solid cancers and monotherapy or in combination with cetuximab in recurrent or metastatic head and neck cancer. International journal of cancer (2023)
Jeong Min Cho, Yong Chul Kim, Sang-Il Min, Tae Min Kim, Hajeong Lee
T cell posttransplant lymphoproliferative disorder after kidney transplantation progressing to acute liver failure: a case report. Korean journal of transplantation (2023)
Sehhoon Park, Tae Min Kim, Ji-Youn Han, Gyeong-Won Lee, Byoung Yong Shim, Yun-Gyoo Lee, Sang-We Kim, Il Hwan Kim, Suee Lee, Yu Jung Kim, Ji Hyun Park, Sang-Gon Park, Ki Hyeong Lee, Eun Joo Kang, Ju Won Kim, Seong Hoon Shin, Chan-Young Ock, Byung-Ho Nam, Jaebong Lee, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn
A Phase 3, Randomized study of atezolizumab plus bevacizumab and chemotherapy in patients with EGFR or ALK mutated in non-small cell lung cancer (ATTLAS, KCSG-LU19-04). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Tae Min Kim, Nicolas Girard, Natasha B Leighl, Joshua Sabari, Nora Rahhali, Claudio A Schioppa, Joris Diels, Jan Sermon, Conor Chandler, Venediktos Kapetanakis, Ruhee Jain, Tracy Li, Suzy Van Sanden
Matching-adjusted indirect comparison of amivantamab vs mobocertinib in platinum-pretreated EGFR Exon 20 insertion-mutated non-small-cell lung cancer. Future oncology (London, England) (2023)
Yuqin Song, Herve Tilly, Shinya Rai, Huilai Zhang, Jie Jin, Hideki Goto, Yasuhito Terui, Ho-Jin Shin, Won Seog S Kim, Junning Cao, Jifeng Feng, Hyeon Seok Eom, Tae Min Kim, Xavier Cheng-Hong Tsai, Jyh-Pyng Gau, Hideo Koh, Liling Zhang, Yongping Song, Yu Yang, Wei Li, He Huang, Kiyoshi Ando, Jeff P Sharman, Laurie H Sehn, Lilian Bu, Xin Wang, Yanwen Jiang, Jamie Hirata, Calvin Lee, Jun Zhu, Koji Izutsu
Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the Phase 3 POLARIX trial. Blood (2023)
Yuqin Song, Herve Tilly, Shinya Rai, Huilai Zhang, Jie Jin, Hideki Goto, Yasuhito Terui, Ho-Jin Shin, Won Seog S Kim, Junning Cao, Jifeng Feng, Hyeon Seok Eom, Tae Min Kim, Xavier Cheng-Hong Tsai, Jyh-Pyng Gau, Hideo Koh, Liling Zhang, Yongping Song, Yu Yang, Wei Li, He Huang, Kiyoshi Ando, Jeff P Sharman, Laurie H Sehn, Lilian Bu, Xin Wang, Yanwen Jiang, Jamie Hirata, Calvin Lee, Jun Zhu, Koji Izutsu
Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the Phase 3 POLARIX trial. Blood (2023)
Adam J Olszewski, Tycel Jovelle Phillips, Marc S Hoffmann, Philippe Armand, Tae Min Kim, Dok Hyun Yoon, Amitkumar Mehta, Richard Greil, Jason R Westin, Izidore S Lossos, Javier L Muñoz, Jason Sit, Michael C Wei, Annie Yang, Vivian Chen, Enkhtsetseg Purev, Donald L Yee, Ulrich Jäger
Mosunetuzumab in combination with CHOP in previously untreated DLBCL: safety and efficacy results from a phase 2 study. Blood advances (2023)
Seung-Won Choi, Hyun Ae Jung, Hee-Jin Cho, Tae Min Kim, Chul-Kee Park, Do-Hyun Nam, Se-Hoon Lee
A multicenter, phase II trial of GC1118, a novel anti-EGFR antibody, for recurrent glioblastoma patients with EGFR amplification. Cancer medicine (2023)
Catherine Thieblemont, Tycel Jovelle Phillips, Hervé Ghesquières, Chan Yoon Y Cheah, Michael Roost Clausen, David Cunningham, Young Rok Do, Tatyana Feldman, Robin Gasiorowski, Wojciech Jurczak, Tae Min Kim, David John Lewis, Marjolein van der Poel, Michelle Limei Poon, Mariana Cota Stirner, Nurgul Kilavuz, Christopher Chiu, Menghui Chen, Mariana Sacchi, Brian Elliott, Tahamtan Ahmadi, Martin Hutchings, Pieternella J Lugtenburg
Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
James Chih-Hsin Yang, Caicun Zhou, Pasi A Jänne, Suresh S Ramalingam, Tae Min Kim, Gregory J Riely, Alexander I Spira, Zofia Piotrowska, Tarek Mekhail, Maria Rosario Garcia Campelo, Enriqueta Felip, Lyudmila Bazhenova, Shu Jin, Manmit Kaur, Paul M Diderichsen, Neeraj Gupta, Veronica Bunn, Jianchang Lin, Eric Churchill, Minal Mehta, Danny Nguyen
Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for EGFR exon 20 insertion-positive non-small cell lung cancer. Expert review of anticancer therapy (2022)
H Chung, H Seo, Seung Hong Choi, Chul-Kee Park, Tae Min Kim, Hye-Kyung Park, Jae Kyoung Won, Soon Tae Lee, S-T Lee, Ji Ye Lee, Inpyeong Hwang, Koung Mi Kang, Tae Jin Yun
Cluster Analysis of DSC MRI, Dynamic Contrast-Enhanced MRI, and DWI Parameters Associated with Prognosis in Patients with Glioblastoma after Removal of the Contrast-Enhancing Component: A Preliminary Study. AJNR. American journal of neuroradiology 43 (11) (2022)
James Chih-Hsin Yang, Caicun Zhou, Pasi A Jänne, Suresh S Ramalingam, Tae Min Kim, Gregory J Riely, Alexander I Spira, Zofia Piotrowska, Tarek Mekhail, Maria Rosario Garcia Campelo, Enriqueta Felip, Lyudmila Bazhenova, Shu Jin, Manmit Kaur, Paul M Diderichsen, Neeraj Gupta, Veronica Bunn, Jianchang Lin, Eric N Churchill, Minal Mehta, Danny Nguyen
Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for EGFR exon 20 insertion-positive non-small cell lung cancer. Expert review of anticancer therapy 23 (1) (2022)
Sehhoon Park, Hongui Cha, Hong Sook Kim, Boram Lee, Soyeon Kim, Tae Min Kim, Hyun Ae Jung, Jong-Mu Sun, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park, Woong-Yang Park, Se-Hoon Lee
Transcriptional upregulation of CXCL13 is correlated with a favorable response to immune checkpoint inhibitors in lung adenocarcinoma. Cancer medicine (2022)
Jae Hyun Kim, Yong Jin An, Tae Min Kim, Jeong Eun Kim, Sunghyouk Park, Seung Hong Choi
Ex vivo NMR metabolomics approach using cerebrospinal fluid for the diagnosis of primary CNS lymphoma: Correlation with MR imaging characteristics. Cancer medicine (2022)
Maria Rosario Garcia Campelo, Caicun Zhou, Suresh S Ramalingam, Huamao M Lin, Tae Min Kim, Gregory J Riely, Tarek Mekhail, Danny Nguyen, Erin Goodman, Minal Mehta, Sanjay Popat, Pasi A Jänne
Mobocertinib (TAK-788) in EGFR Exon 20 Insertion+ Metastatic NSCLC: Patient-Reported Outcomes from EXCLAIM Extension Cohort. Journal of clinical medicine 12 (1) (2022)
Maria Rosario Garcia Campelo, Caicun Zhou, Suresh S Ramalingam, Huamao M Lin, Tae Min Kim, Gregory J Riely, Tarek Mekhail, Danny Nguyen, Erin Goodman, Minal Mehta, Sanjay Popat, Pasi A Jänne
Mobocertinib (TAK-788) in EGFR Exon 20 Insertion+ Metastatic NSCLC: Patient-Reported Outcomes from EXCLAIM Extension Cohort. Journal of clinical medicine 12 (1) (2022)
Catherine Thieblemont, Tycel Jovelle Phillips, Hervé Ghesquières, Chan Yoon Y Cheah, Michael Roost Clausen, David Cunningham, Young Rok Do, Tatyana Feldman, Robin Gasiorowski, Wojciech Jurczak, Tae Min Kim, David John Lewis, Marjolein van der Poel, Michelle Limei Poon, Mariana Cota Stirner, Nurgul Kilavuz, Christopher Chiu, Menghui Chen, Mariana Sacchi, Brian Elliott, Tahamtan Ahmadi, Martin Hutchings, Pieternella J Lugtenburg
Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
James Chih-Hsin Yang, Caicun Zhou, Pasi A Jänne, Suresh S Ramalingam, Tae Min Kim, Gregory J Riely, Alexander I Spira, Zofia Piotrowska, Tarek Mekhail, Maria Rosario Garcia Campelo, Enriqueta Felip, Lyudmila Bazhenova, Shu Jin, Manmit Kaur, Paul M Diderichsen, Neeraj Gupta, Veronica Bunn, Jianchang Lin, Eric Churchill, Minal Mehta, Danny Nguyen
Expert review of anticancer therapy (2022)
Maria Rosario Garcia Campelo, Caicun Zhou, Suresh S Ramalingam, Huamao M Lin, Tae Min Kim, Gregory J Riely, Tarek Mekhail, Danny Nguyen, Erin Goodman, Minal Mehta, Sanjay Popat, Pasi A Jänne
Mobocertinib (TAK-788) in EGFR Exon 20 Insertion+ Metastatic NSCLC: Patient-Reported Outcomes from EXCLAIM Extension Cohort. Journal of clinical medicine 12 (1) (2022)
Maria Rosario Garcia Campelo, Caicun Zhou, Suresh S Ramalingam, Huamao M Lin, Tae Min Kim, Gregory J Riely, Tarek Mekhail, Danny Nguyen, Erin Goodman, Minal Mehta, Sanjay Popat, Pasi A Jänne
Mobocertinib (TAK-788) in EGFR Exon 20 Insertion+ Metastatic NSCLC: Patient-Reported Outcomes from EXCLAIM Extension Cohort. Journal of clinical medicine 12 (1) (2022)
James Chih-Hsin Yang, Caicun Zhou, Pasi A Jänne, Suresh S Ramalingam, Tae Min Kim, Gregory J Riely, Alexander I Spira, Zofia Piotrowska, Tarek Mekhail, Maria Rosario Garcia Campelo, Enriqueta Felip, Lyudmila Bazhenova, Shu Jin, Manmit Kaur, Paul M Diderichsen, Neeraj Gupta, Veronica Bunn, Jianchang Lin, Eric N Churchill, Minal Mehta, Danny Nguyen
Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for EGFR exon 20 insertion-positive non-small cell lung cancer. Expert review of anticancer therapy 23 (1) (2022)
Soonbum Park, Eun A Cho, Jung Nyeo Chun, Da Young Lee, Sanghoon Lee, Mi Yeon Kim, Sang Mun Bae, Su In Jo, So Hee Lee, Hyun Ho Park, Tae Min Kim, Insuk So, Sang-Yeob Kim, Ju-Hong Jeon
Crizotinib attenuates cancer metastasis by inhibiting TGFβ signaling in non-small cell lung cancer cells. Experimental & molecular medicine 54 (8) (2022)
David A Reardon, Tae Min Kim, Jean-Sebastien Frenel, Matteo Simonelli, Juanita Lopez, Deepa S Subramaniam, Lillian L Siu, Hui Wang, Suba Krishnan, Karen Stein, Christophe Massard
Treatment with pembrolizumab in programmed death ligand 1-positive recurrent glioblastoma: Results from the multicohort phase 1 KEYNOTE-028 trial. Cancer 127 (10) (2021)
Hyunhee Kim, Ka Young Lim, Jin Woo Park, Jeongwan Kang, Jae Kyung Won, Kwanghoon Lee, Yu-Mi Shim, Chul-Kee Park, Seung-Ki Kim, Seung-Hong Choi, Tae Min Kim, Hongseok Yun, Hye-Kyung Park
Sporadic and Lynch syndrome-associated mismatch repair-deficient brain tumors. Laboratory investigation; a journal of technical methods and pathology (2021)
Elena Pak, Kyu Sung Choi, Seung Hong Choi, Chul-Kee Park, Tae Min Kim, Hye-Kyung Park, Joo Ho Lee, Soon Tae Lee, Inpyeong Hwang, Roh-Eul Yoo, Koung Mi Kang, Tae Jin Yun, Ji Hoon Kim, Chul-Ho Sohn
Prediction of Prognosis in Glioblastoma Using Radiomics Features of Dynamic Contrast-Enhanced MRI. Korean journal of radiology 22 (9) (2021)
June Young Chun, Se Ik Kim, Eun Young Park, Sang-Yoon Park, Su-Jin Koh, Yongjun Cha, Heon Jong Yoo, Jae Young Joung, Hong Man Yoon, Bang Wool Eom, Chul Min Park, Ji-Youn Han, Miso Kim, Dae-Won Lee, Jae-Weon Kim, Bhumsuk Keam, Maria Lee, Tae Min Kim, Young Ju Choi, Yoon Jung Chang, Myong Cheol Lim
Cancer Patients' Willingness to Take COVID-19 Vaccination: A Nationwide Multicenter Survey in Korea. Cancers 13 (15) (2021)
Min-Gu Kang, Han Gil Seo, Eun-Jae Chung, Hyun Haeng Lee, Seo Jung Yun, Bhumsuk Keam, Tae Min Kim, Seong Keun Kwon, Byung-Mo Oh
Effects of percutaneous injection laryngoplasty on voice and swallowing problems in cancer-related unilateral vocal cord paralysis. Laryngoscope investigative otolaryngology 6 (4) (2021)
Laurie H Sehn, Mark Hertzberg, Stephen Samuel Opat, Alex F Herrera, Sarit Assouline, Christopher R Flowers, Tae Min Kim, Andrew K McMillan, Muhit Özcan, Violaine Safar, Gilles Andre Salles, Grace Ku, Jamie Hirata, Yi Meng Chang, Lisa Musick, Matthew J Matasar
Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory DLBCL: survival update and new extension cohort. Blood advances (2021)
Jürgen Wolf, Takashi Seto, Ji-Youn Han, Noemi Reguart, Edward B Garon, Harry J M Groen, Daniel S W Tan, Toyoaki Hida, Maja de Jonge, Sergey V Orlov, Egbert F Smit, Pierre-Jean Souquet, Johan Vansteenkiste, Maximilian Hochmair, Enriqueta Felip, Makoto Nishio, Michael Thomas, Kadoaki Ohashi, Ryo Toyozawa, Tobias R Overbeck, Filippo de Marinis, Tae Min Kim, Eckart Laack, Anna Robeva, Sylvie Le Mouhaer, Maeve Waldron-Lynch, Banu Sankaran, O Alejandro Balbin, Xiaoming Cui, Monica Giovannini, Mikhail Akimov, Rebecca S Heist, null null
Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer. The New England journal of medicine 383 (10) (2020)
Eun Kyoung Hong, Seung Hong Choi, Dong Jae Shin, Sang Won Jo, Roh-Eul Yoo, Koung Mi Kang, Tae Jin Yun, Ji Hoon Kim, Chul-Ho Sohn, Hye-Kyung Park, Jae Kyoung Won, Tae Min Kim, Chul-Kee Park, Il Han Kim, Soon Tae Lee
Comparison of Genetic Profiles and Prognosis of High-Grade Gliomas Using Quantitative and Qualitative MRI Features: A Focus on G3 Gliomas. Korean journal of radiology 22 (2) (2020)
Inpyeong Hwang, Seung Hong Choi, Chul-Kee Park, Tae Min Kim, Hye-Kyung Park, Jae Kyoung Won, Il Han Kim, Soon Tae Lee, Roh-Eul Yoo, Koung Mi Kang, Tae Jin Yun, Ji Hoon Kim, Chul-Ho Sohn
Dynamic Contrast-Enhanced MR Imaging of Nonenhancing T2 High-Signal-Intensity Lesions in Baseline and Posttreatment Glioblastoma: Temporal Change and Prognostic Value. AJNR. American journal of neuroradiology 41 (1) (2019)
Ye Eun Kim, Tae Min Kim, Seong Jin Jo
Histologically-diagnosed psoriasiform dermatitis induced by nivolumab successfully controlled by etanercept: A case report. The Journal of dermatology 46 (12) (2019)
Changhee Park, Tae Min Kim, Chan-Young Ock, Bhumsuk Keam, Dong Wan Kim, Dae Seog Heo
Clinical Application of Next-Generation Sequencing-Based Panel to BRAF Wild-Type Advanced Melanoma Identifies Key Oncogenic Alterations and Therapeutic Strategies. Molecular cancer therapeutics 19 (3) (2019)
S H Kim, K H Cho, Seung Hong Choi, Tae Min Kim, Chul-Kee Park, Hye-Kyung Park, Jae Kyoung Won, Il Han Kim, Soon Tae Lee
Prognostic Predictions for Patients with Glioblastoma after Standard Treatment: Application of Contrast Leakage Information from DSC-MRI within Nonenhancing FLAIR High-Signal-Intensity Lesions. AJNR. American journal of neuroradiology 40 (12) (2019)
So Hyun Bae, Min Jung Park, Min Mi Lee, Tae Min Kim, Se-Hoon Lee, Sung Yun Cho, Young-Hoon Kim, Yu Jung Kim, Chul-Kee Park, Chae-Yong Kim
Toxicity profile of temozolomide in the treatment of 300 malignant glioma patients in Korea. Journal of Korean medical science 29 (7) (2014)